Overview

Study To Evaluate The Effect Of Multiple Doses of CTP-543 On The Pharmacokinetics Of Single Doses of Midazolam In Healthy Subjects

Status:
Completed

Trial end date:
2022-07-07

Target enrollment:

Participant gender:

Summary

This is a single center, Phase 1, open-label, fixed-sequence, drug-drug interaction study to determine the effect of CTP-543 on the pharmacokinetics (PK) of midazolam in healthy adult subjects

Phase:

Phase 1

Details

Lead Sponsor:

Concert Pharmaceuticals

Treatments:

Midazolam